A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS 181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Child to Adult
Locations
Childrens Hospital Colorado
Principal Investigator
![Photograph of Hesham Eissa](https://som.ucdenver.edu/FIMS/Content/faculty/26958/CU-Doctors-26958.jpg)
Hesham Eissa
Study ID
Protocol Number: 19-0853
More information available at ClinicalTrials.gov: NCT03808922
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers